LIXT logo
LIXT NASDAQ US

Lixte Biotechnology Holdings, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Sep 2007
$3.05
▼ $-0.02 (-0.65%)
Vol 22K
3
Quality Score
fail
Mkt Cap
$31.5M
ROE
-216.3%
D/E
0.00
Beta
0.99
52W
$1–$6

Price Chart

Earnings

Beat rate: 0.0%
Next Report May 11, 2026
Quarter EPS Est EPS Act Surprise
Mar 2026
Dec 2024 $-0.27

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -308.5% -308.5% -308.5% -308.5% -308.5% -216.3%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.84 1.84 1.84 1.84 1.84 10.42

Key Ratios

ROA (TTM)
-176.0%
P/B
5.5
EPS (TTM)
$-1.17
52W High
$6.26
52W Low
$0.64
$0.64 52-Week Range $6.26

How does LIXT compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

LIXT AAPG ABEO ABOS ABP

LIXT valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
5.5
124% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

LIXT profitability vs Biotechnology peers

ROE
-216.3%
221% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-176.0%
277% below peers (-46.7%)
vs Peers
vs Industry
Weak

LIXT financial health vs Biotechnology peers

D/E ratio
0.0
0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
10.4
135% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.0
2% above peers (1.0)
vs Peers
vs Industry
Less volatile

LIXT fundamentals radar

LIXT Peer median Industry

LIXT profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

LIXT vs peers: key metrics

Latest News

No related news yet